{"Ticker": "ABBV", "Company": "AbbVie", "Sector": "Health Care", "Updated": "2022-05-06", "Rating": [{"Date": "2022-05-06", "Rating": "Downgrade", "Organization": "Daiwa Securities", "Rating_Change": "Outperform to Neutral", "Target_Change": "$150"}, {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$192"}, {"Date": "2022-02-28", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$129 to $147"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$117 to $122"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$135 to $138"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$153 to $154"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$133 to $150"}, {"Date": "2022-01-13", "Rating": "Initiated", "Organization": "Redburn", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2022-01-12", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$134 to $153"}, {"Date": "2021-12-09", "Rating": "Resumed", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$165"}, {"Date": "2021-11-23", "Rating": "Upgrade", "Organization": "Societe Generale", "Rating_Change": "Hold to Buy", "Target_Change": "$172"}, {"Date": "2021-07-27", "Rating": "Resumed", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$118"}, {"Date": "2021-04-07", "Rating": "Resumed", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$135"}, {"Date": "2020-11-10", "Rating": "Resumed", "Organization": "Bernstein", "Rating_Change": "Outperform", "Target_Change": "$120"}, {"Date": "2020-09-29", "Rating": "Initiated", "Organization": "Berenberg", "Rating_Change": "Hold", "Target_Change": "$98"}, {"Date": "2020-06-23", "Rating": "Upgrade", "Organization": "Atlantic Equities", "Rating_Change": "Neutral to Overweight", "Target_Change": "$115"}, {"Date": "2020-06-09", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": ""}, {"Date": "2020-06-02", "Rating": "Upgrade", "Organization": "Argus", "Rating_Change": "Hold to Buy", "Target_Change": "$115"}, {"Date": "2020-05-18", "Rating": "Resumed", "Organization": "BofA/Merrill", "Rating_Change": "Neutral", "Target_Change": "$95"}, {"Date": "2020-05-12", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$105"}, {"Date": "2020-05-11", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$95"}, {"Date": "2020-04-20", "Rating": "Upgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Outperform", "Target_Change": "$79 to $93"}, {"Date": "2020-03-23", "Rating": "Downgrade", "Organization": "Societe Generale", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2020-02-27", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$97"}, {"Date": "2020-02-06", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2020-01-07", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$86"}, {"Date": "2019-12-26", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$90 to $98"}, {"Date": "2019-09-26", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$87 to $90"}, {"Date": "2019-08-20", "Rating": "Upgrade", "Organization": "Piper Jaffray", "Rating_Change": "Neutral to Overweight", "Target_Change": "$80"}]}